KRM Ayurveda
CLOSEDIPO Date: 21 Jan - 23 Jan 2026
Listing Date: 29 Jan 2026
Price Range
Rs.128 - Rs.135
Issue Size
77 Cr
Min Investment
₹1,28,000
Lot Size
1000 Shares
Schedule of KRM Ayurveda
Issue open date
21 Jan 2026
Issue close date
23 Jan 2026
UPI mandate deadline
23 Jan 2026 (5 PM)
Allotment finalization
27 Jan 2026
Share credit
28 Jan 2026
Listing date
29 Jan 2026
Mandate end date
7 Feb 2026
Issue size
| Funds Raised in the IPO | Amount |
|---|---|
| Overall | 77 Cr |
| Fresh Issue | 77.49 Cr |
| Offer for Sale | 0 Cr |
Allotment DetailsNew
| Allotment Timeline | Details |
|---|---|
| Allotment Date | 27 Jan 2026 |
| Allotment Link | {Link} |
Grey Market PremiumNew
Grey Market Premium (GMP) is the premium at which the shares are traded in the grey market. It gives a fair idea about the listing price of the IPO shares. The GMP can be positive or negative based on the demand and supply of the shares in the grey market.
| Date | Ipo Price | GMP | Estimated Listing Price |
|---|---|---|---|
| 28 Jan 2026 | ₹135 | ₹23 | ₹158 (16.67%) |
| 26 Jan 2026 | ₹135 | ₹19 | ₹154 (14.07%) |
| 25 Jan 2026 | ₹135 | ₹17 | ₹152 (12.59%) |
| 24 Jan 2026 | ₹135 | ₹17 | ₹152 (12.59%) |
| 22 Jan 2026 | ₹135 | ₹16 | ₹151 (11.85%) |
| 20 Jan 2026 | ₹135 | ₹21 | ₹156 (15.56%) |
| 19 Jan 2026 | ₹135 | ₹20 | ₹155 (14.81%) |
| 18 Jan 2026 | ₹135 | ₹20 | ₹155 (14.81%) |
| 17 Jan 2026 | ₹135 | ₹20 | ₹155 (14.81%) |
| 16 Jan 2026 | ₹135 | ₹18 | ₹153 (13.33%) |
| 15 Jan 2026 | ₹135 | ₹15 | ₹150 (11.11%) |
| 14 Jan 2026 | ₹135 | ₹0 | ₹135 (0%) |
Performance KRM Ayurveda
| Issue Price | Listing Gain | Current Market Price | P/L |
|---|---|---|---|
| Rs.128 - Rs.135 | ₹ 379 (27.48%) | ₹ 202 | 49.63% |
About KRM Ayurveda
KRM Ayurveda is a healthcare company that operates a network of Ayurveda-based hospitals and clinics providing treatment for chronic and lifestyle-related health conditions. Its services cover inpatient and outpatient care for disorders such as kidney disease, liver cirrhosis, diabetes, fatty liver, arthritis, and other long-term ailments, along with post-operative rehabilitation. The company provides Panchakarma procedures, runs focused clinics for orthopaedic issues, skin and hair concerns, women’s health, and elderly care, and offers structured wellness plans for stress, weight, and preventive health. It also dispenses its own and other approved Ayurvedic medicines through in-house pharmacies and provides diet, nutrition, and yoga guidance. Established in 2019, the company currently operates six hospitals and five clinics at different locations in India and serves overseas patients through online consultations and medicine sales, using teleconsultation channels to extend access to its doctors beyond its physical centres.
| Founded in | 2019 |
| Managing director | Mr Puneet Dhawan |
| Parent organization |
Financial Overview
Strengths
- Integrated Ayurvedic healthcare model combining hospitals, clinics, and telemedicine.
- Strong promoter experience with deep domain knowledge in Ayurveda.
- Specialised expertise in chronic and lifestyle disease management.
- Growing physical presence across multiple Indian states with global tele-reach.
- Increasing brand recognition in the D2C and holistic healthcare segment.
Risks
- High dependence on North India for a significant portion of revenues.
- Operations are asset-light, with most hospitals and clinics on leased premises.
- Business is working-capital intensive with a history of negative cash flows.
- High employee attrition could impact service quality and scalability.
- Dependence on brand reputation in a highly competitive and unregulated AYUSH market.
Subscription Figures
| Category | Subscription (No. of times) |
|---|---|
| Qualified Institutional Buyers (QIBs) | 61.52 |
| Non-Institutional Investors (NIIs) | 86.51 |
| Retail Individual Investors (RIIs) | 51.61 |
| Employee | N/A |
| Total | 63.75 |